Performance of leflunomide as a steroid-sparing agent in giant cell arteritis: A single-center, open-label study

BACKGROUND: The management of giant cell arteritis (GCA) remains challenging and many patients require prolonged glucocorticoid treatment due to high disease relapse rates. We aimed to evaluate the role of leflunomide as a steroid-sparing agent in GCA. METHODS: This prospective open-label study incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kramarič, Jelka, Rotar, Žiga, Tomšič, Matija, Hočevar, Alojzija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684628/
https://www.ncbi.nlm.nih.gov/pubmed/36438047
http://dx.doi.org/10.3389/fmed.2022.1069013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684628/
https://www.ncbi.nlm.nih.gov/pubmed/36438047
http://dx.doi.org/10.3389/fmed.2022.1069013

Ejemplares similares